AnaptysBio SG&A Expense (TTM) Insights

AnaptysBio Inc (ANAB)

31.87 -0.64 (-1.97%) USD | NASDAQ | Sep 27, 16:00

31.86 -0.01 (-0.03%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
June 30, 2024	42.08M
March 31, 2024	43.47M
December 31, 2023	41.95M
September 30, 2023	41.08M
June 30, 2023	39.77M
March 31, 2023	37.26M
December 31, 2022	36.64M
September 30, 2022	32.63M
June 30, 2022	29.20M
March 31, 2022	26.27M
December 31, 2021	21.49M
September 30, 2021	21.19M
June 30, 2021	20.55M
March 31, 2021	19.99M
December 31, 2020	18.85M
September 30, 2020	17.60M
June 30, 2020	16.62M
March 31, 2020	16.24M
December 31, 2019	16.09M

Date	Value
September 30, 2019	16.00M
June 30, 2019	16.20M
March 31, 2019	15.72M
December 31, 2018	15.53M
September 30, 2018	14.33M
June 30, 2018	12.71M
March 31, 2018	11.23M
December 31, 2017	9.338M
September 30, 2017	7.705M
June 30, 2017	6.322M
March 31, 2017	5.124M
December 31, 2016	4.29M
September 30, 2016	4.452M
June 30, 2016	4.334M
March 31, 2016	4.126M
December 31, 2015	3.589M
September 30, 2015	3.089M
June 30, 2015	2.75M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

16.00M

Minimum

Sep 2019

43.47M

Maximum

Mar 2024

27.75M

Average

23.88M

Median

SG&A Expense (TTM) Benchmarks